About GUOTAI ASSET MANAGEMENT CO CHINA SECS SHANGHAI HONG KONG SHENZHEN E

517110 invests in stocks. The fund's major sectors are Health Technology, with 88.42% stocks, and Commercial Services, with 0.88% of the basket. The assets are mostly located in the Asia region.

517110 top holdings are WuXi AppTec Co., Ltd. Class A and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A, occupying 10.36% and 10.23% of the portfolio correspondingly.

517110 assets under management is ‪274.51 M‬ CNY. It's risen 8.20% over the last month.

517110 fund flows account for ‪46.05 M‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

No, 517110 doesn't pay dividends to its holders.

517110 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.

517110 follows the CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

517110 invests in stocks.

517110 price has risen by 12.78% over the last month, and its yearly performance shows a 36.83% increase. See more dynamics on 517110 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 16.56% over the last month, showed a 14.56% increase in three-month performance and has increased by 44.13% in a year.